Health

Uzbekistan updates criteria for classifying over-the-counter medicines

Illustration: Tezkun / AI. Not a photograph of the event.

On November 12, the Ministry of Justice registered amendments prepared by the Ministry of Health to the regulation determining which medications are prescription-only and which are dispensed over the counter. The document was published on Lex.uz.

The new rules will come into effect three months after their official publication. They specify the criteria under which a medication may be approved for over-the-counter sale. Factors considered include whether the drug can be taken independently and safely without continuous medical supervision, how low the risk of incorrect intake, overdose, abuse, and dependence is, and whether the package leaflet is clear to the consumer. Pharmacovigilance and post-marketing surveillance data are also taken into account, as well as whether the drug has been approved for over-the-counter status by WHO-recognized regulatory authorities.

Combination drugs containing two or more active substances can now also be sold over the counter. In such cases, regulators will evaluate the contribution of each component to the treatment, the benefit-risk ratio of their combination, clinical justification, as well as the risks of interaction, overdose, and improper use.

The procedure for re-applications has also changed. Previously, after a refusal to reclassify a drug from prescription-only to over-the-counter, one had to wait three years. An applicant is now entitled to reapply before this period expires if the reasons for the refusal are resolved or if fresh data emerges regarding the drug's safety and efficacy.

The Center for Pharmaceutical Products Safety (Uzpharmcontrol) will be able to review a medication's category. Grounds for review include new safety or efficacy data, pharmacovigilance and post-marketing monitoring findings, as well as legislative changes.

What it means

The changes will take effect three months after official publication. They affect applicants seeking to switch drugs to over-the-counter status: after a refusal, they can reapply earlier than the previous three-year waiting period if the grounds for refusal are resolved or new safety and efficacy data emerges. Drugs with two or more active substances can also be dispensed over the counter.

Published 16 November 2026, 10:16 · No updates · Russian original

Discussion
  1. Loading comments…
No links or insults. One comment per 20 seconds.

Comments on this story live under its post in our Telegram channel. Comment on Telegram